Top Markets
#1 Islamic Coin Islamic Coin +151.50%
#2 DOVU DOVU +50.13%
#3 Black Phoenix Black Phoenix +35.32%
#4 Velvet Velvet +31.51%
#5 Akedo Akedo +19.78%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.32%
#7 Fake World Assets Fake World Assets +17.01%
#8 DoubleZero DoubleZero +12.65%
#9 clBTC clBTC +11.86%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.21%
Coin of the day
Islamic Coin Islamic Coin
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Rankning i aktier #39914
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Aktiekurs
$0.00366968
Senast synkroniserad: 2024-07-12
Marknadsvärde
$299.46K
Förändring (1 dag)
-66.77%
Förändring (1 år)
0.00%
Land
CA
Handel Biocure Technology Inc. (CURE)

Kategori

Healthcare
Antal utestående aktier för Biocure Technology Inc. (CURE)
Antal utestående aktier per August 2026: 0
Enligt de senaste finansiella rapporterna och aktiekursen för Biocure Technology Inc. är det aktuella antalet utestående aktier 0. I slutet av August 2026 hade företaget 0 utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Biocure Technology Inc. (CURE) från 2026 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
Inte tillräckligt med data för de angivna datumen.
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE